Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer

Published:2016-06-20 Issue:6 Volume:11 Page:e0157836
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dong Xinzhe,Sun Xiaorong,Sun Lu,Maxim Peter G.,Xing Lei,Huang Yong,Li Wenwu,Wan Honglin,Zhao Xianguang,Xing Ligang,Yu Jinming

Funder

National Health and Family Planning Commission Institutes of the People’s Republic of China

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

China Scholarship Council

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;A Auperin;J Clin Oncol,2010

2. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study;JD Bradley;Lancet Oncol,2015

3. PET-CT for radiotherapy treatment planning and response monitoring in solid tumors;J Bussink;Nat Rev Clin Oncol,2011

4. Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial;M Machtay;J Clin Oncol,2013

5. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project;T Berghmans;J Thorac Oncol,2008

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma;Annals of Hematology;2024-07-24

2. Machine learning-based analysis of 68Ga-PSMA-11 PET/CT images for estimation of prostate tumor grade;Physical and Engineering Sciences in Medicine;2024-03-25

3. Heterogeneity of Glycolytic Phenotype Determined by 18F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer;Diagnostics;2023-07-22

4. [18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications;Seminars in Nuclear Medicine;2022-11

5. A nomogram based on 18F-fluorodeoxyglucose PET/CT and clinical features to predict epidermal growth factor receptor mutation status in patients with lung adenocarcinoma;Quantitative Imaging in Medicine and Surgery;2022-11